Jing-Tao Wu

Jing-Tao Wu is an accomplished pharmaceutical executive with extensive experience in early development and drug metabolism and pharmacokinetics (DMPK). Currently serving as Senior Vice President of Early Development at Alnylam Pharmaceuticals since July 2017, Jing-Tao Wu previously held the position of Vice President in the same department. Prior to Alnylam, Jing-Tao Wu worked at Takeda from February 2002 to July 2017 as Senior Director and Site Head of DMPK. Before that, Jing-Tao Wu gained valuable expertise as a Senior Research Scientist at DuPont Pharmaceuticals from June 1997 to January 2002 and briefly served as a Senior Research Investigator at Bristol-Myers Squibb Co in 2002. Academic qualifications include a PhD in Chemistry from the University of Michigan (1993-1997) and a Bachelor of Science in Chemistry from Fudan University (1986-1990).